N/A N=251 Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption
Placenta, Retained · Postpartum Hemorrhage
Primary: Placental Retention Rate — 26; 8; 24 participants — p=0.05
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=60 Histerectomy Vs Partial Myometrial Resection for Placenta Accreta Spectrum
Placenta Accreta
Primary: Feasibility: Proportion of Eligible Patients Who Agree to Participate in the Study. — 60 Participants
N/A N=120 Influence of Acupuncture in the Placental Expulsion Time
Placental Expulsion Time
Primary: The Principal Outcome of the Study is the Placental Expulsion Time. — 15.21; 5.23 minutes — p=<0.001
N/A N=106 Accuracy of Blood Loss Estimation After Vaginal Delivery
Postpartum Hemorrhage
Primary: Difference in Actual Blood Volume and Estimated Blood Volume in Milliliters. — -20.8; -41.7; -53.5; -96.0 milliliters — p=<0.05
N/A N=102 Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device (IUD) After Vaginal Delivery
Contraception
Primary: IUD Usage Rate at 6 Months — 43; 39 participants
N/A N=60 Predicting Placental Pathologies by Ultrasound Imaging
Intrauterine Growth Restriction · Villitis · IUGR
Primary: Number of Participants With Uterine Artery Indices Completed — 13; 3 Participants
Early Phase 1 N=3 Placental Lesions in Fetal Growth Restrictions
Fetal Growth Retardation
Primary: Number of Participants for Which Intervillous Placental Blood is Detected — 3 Participants
N/A N=29 Mirena Intrauterine System Timing of Insertion: A Randomized Controlled Trial
Postpartum Period
Primary: Mirena in Place — 10; 3 participants
N/A N=68 Optimal Management of Vasa Previa Study - A Retrospective Study
Vasa Previa
Primary: Diagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy. — 47; 13; 4; 2 Participants
N/A N=112 Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial
Intrauterine Devices · Cesarean Section
Primary: IUD Use — 32; 40 participants
Phase 3 N=120 Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
Uterine Atony · Uterine Atony With Hemorrhage · Postpartum Hemorrhage
Primary: Quantitative Blood Loss — 840; 1051 milliliters — p=<0.05
N/A N=5 Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Artery
Intrauterine Growth Retardation
Primary: Survival — 100; 100 percentage of AGA babies who survived
Phase 3 N=95 Labor and Delivery Implant Insertion: A Randomized Controlled Trial
Postpartum Contraception · Family Planning
Primary: Time to Lactogenesis Stage II [Questionnaire] — 65; 67.5 hours
Phase 3 N=153 Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy
Intrauterine Fetal Demise
Primary: Successful Expulsion of Fetus and Placenta Within 48 Hours — 60; 47 participants — p=<0.05
N/A N=50 TUI 3D in Diagnosis of Placenta Accreta: Comparison With Gray-scale and Color Doppler Techniques
Placenta Accreta
Primary: Loss of the Retro Placental Sonolucent Zone by 2D Grayscale Ultrasonography — 12; 19 participants
Phase 4 N=59 Immediate vs. Delayed Postpartum Etonogestrel Implant
Continuation Rate of Contraceptive Implant
Primary: Continuation Rate — 20; 18 participants
N/A N=123 Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study
Contraception
Primary: IUD Expulsion Rate — 20; 7 Participants
Phase 4 N=284 Uterotonic Prophylaxis Trial
Hemorrhage
Primary: Number of Participants With Excessive Bleeding as Determined by the Composite Outcome Criteria — 78; 75 Participants — p=0.5
Phase 4 N=29 A Pilot Study of Early Postpartum Intrauterine Contraception
Unplanned Pregnancy
Primary: IUD Expulsion — 11 Participants
Phase 4 N=88 'Levonorgestrel IUD Insertion After D&E Procedure
Contraceptive Usage
Primary: The Primary Outcome is LNG-IUD Usage Six Months Following Enrollment. — 85.2; 62.9 percentage of participants — p=0.05
N/A N=166 Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation
Abortion · Dilation and Evacuation · Hemorrhage
Primary: Rate at Which Providers Intervene to Control Blood Loss During D&E Procedures. — 13; 6 Participants
N/A N=74 Cord Clamping Level Above or Below Mother's Perineum
Pre-term Birth · Delayed Cord Clamping
Primary: Hematocrit Level — 51.5; 52.6 % of blood composed of red blood cells — p=0.572
N/A N=995 Neonatal Outcome by Reason for Delivery
Preterm Delivery
Primary: Composite Perinatal Morbidity — 277; 203; 221; 45 participants
Phase 4 N=66 Prophylactic Methylergonovine for Twin Cesarean
Twin; Complicating Pregnancy · Postpartum Hemorrhage
Primary: Change in Maternal Hemoglobin Level — 1.1; 2.1 g/dL
N/A N=150 Bleeding Patterns and Complications After Postpartum IUD Placement: a Pilot Study
Postpartum Period
Primary: Bleeding Patterns — 15; 18; 13; 7 days
Phase 4 N=90 Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery
Intrauterine Device Expulsion
Primary: Number of Participants With Expulsion of IUD — 54; 0 Participants
N/A N=24 Coagulation Factor Changes Associated With Postpartum Hysterectomies
Obstetric Labor Complications · Hemorrhage · Complications; Cesarean Section
Primary: Fibrinogen Level at 2 Hours After Delivery — 186; 418 mg/dL — p=<0.05
N/A N=242 Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population
Pregnancy Complications
Primary: Clinical Estimated Blood Loss (EBL) Between Cases and Controls Using Clinical Estimate Versus Device Assessment — 800; 800 milliLiters
N/A N=150 Pannus Assistance Needed for Obstetric Ultrasound Studies
Obesity Complicating Childbirth · Fetal Anomaly
Primary: Completion Rate of 16 Prespecified Views — 19; 24 Participants
N/A N=60 Severing Nuchal Cord at the Time of Delivery.
Perinatal Outcome
Primary: Umbilical Cord pH — 7.29; 7.32 pH — p=0.1